FAS: PRICES FOR ANTITUMOR MEDICINES WITH INN "SUNITINIB" WERE REDUCED BY 7 TIMES

Such medicines include a foreign reference medicine "Sutent" and four domestic generics

It became possible due to the consistent reduction of registered prices for a foreign reference medicine and the approval by the Authority of the price for a new domestic generic.

Earlier, the manufacturer reduced the prices of the reference medicine "Sutent"
by 4 times. Currently, FAS Russia has agreed on prices for the fourth domestic generic "Valeotinib" in the amount of 1 141 rubles for 1 capsule at a dosage
of 50 mg. According to the law, prices for other generics should also be reduced*.

Reduction of registered prices for medicines with INN "Sunitinib" will allow to reduce the cost of their purchase in Russia. Now the initial maximum contract price calculated by the tariff method** will also be no more than 1 141 rubles per capsule (excluding VAT). Previously, it was 7 297 rubles per capsule for the original medicine.

Such a significant reduction in the cost of  medicines will increase their accessibility for citizens. In medical organizations, they are provided free of charge within the framework of the program of state guarantees of free medical care.

Reference:

* Part 4 of the Article 61 of the Federal Law No. 61-FZ of April 12, 2010 "On Circulation of Medicines".

** Federal Law of April 5, 2013 No. 44-FZ "On the Contract System in the Area of Procurement of Goods, Works and Services for Meeting State and Municipal Needs"  provides for five main methods of calculating and justifying the IMCP: the method of comparable market prices (market analysis); normative method; tariff method; design-estimate method; cost method.